NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: rfXcel Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Columbia Laboratories Selects rfXcel for ePedigree Compliance - Pharmaceutical industry's most production-proven E-Pedigree solution chosen for user-friendliness, solid understanding of customer’s business concerns, and SAP certification
Columbia Laboratories Selects rfXcel for ePedigree Compliance

 

NewswireTODAY - /newswire/ - San Ramon, CA, United States, 2008/08/06 - Pharmaceutical industry's most production-proven E-Pedigree solution chosen for user-friendliness, solid understanding of customer’s business concerns, and SAP certification.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

rfXcel Corporation, a leading provider of production-proven ePedigree Management solutions that allow manufacturers, distributors, and retailers to track the chain of custody of prescription drugs through the pharmaceutical supply chain, today announced that Columbia Laboratories has purchased rfXcel’s Active ePedigree Management™ solution to protect its supply chain.

Based in Livingston, NJ, Columbia develops and markets innovative pharmaceuticals that address women’s healthcare conditions and endocrinology disorders. Each of Columbia’s products and product candidates utilize its novel bioadhesive drug delivery system (BDS), an innovative technology that differentiates Columbia from its competitors and provides a platform for numerous additional future applications.

In preparation for compliance with California’s pending 2011 ePedigree requirements, Columbia Laboratories selected rfXcel’s ePedigree Management™ solution. After evaluating the leading ePedigree software providers, rfXcel was selected for its certification to SAP, its rich set of features, and the ease with which it is to implement, integrate and use. Other key reasons included rfXcel’s customer focus, flexibility, and proven track record in meeting customer needs as they evolve.

“Out of all the vendors we evaluated, rfXcel’s ePedigree Management application is the most feature rich and easy to use”, said Alexander Kay, Senior Director of Operations at Columbia Laboratories. “Furthermore, rfXcel’s management team reflected a sense which seemed to understand our company’s business concerns more than the other companies did.”

“We’re pleased to have been chosen by Columbia Laboratories for our usability, flexibility and successful customer experience track record versus competitive offerings”, said Glenn Abood, Founder and CEO at rfXcel. “Over the past four years we’ve focused on developing the most intuitive, easy to use, and feature rich ePedigree Management application, and it’s great to see that our customers are acknowledging it.”

About rfXcel Corporation

rfXcel, founded in 2003, is headquartered in San Ramon, CA. rfXcel is a pioneer in creating real-time supply-chain performance improvement and compliance applications for retailers, manufacturers and distributors. rfXcel solutions can be implemented today, yet have the capability to scale as infrastructure technology develops. The rfXcel management team and board are comprised of industry experts that come directly from the life sciences, technology and consumer goods industries. rfXcel was founded on the principle of providing real business value to our customers by developing solutions that solve supply chain problems that they face every business day.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: rfXcel Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Columbia Laboratories Selects rfXcel for ePedigree Compliance

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: James McCrory - rfXcel.com 
925-824-0300 jmccrory[.]rfxcel.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any rfXcel Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From rfXcel Corporation / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ono Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases
OPDIVO® Intravenous Infusion Approved in South Korea for the Treatment of Resectable Non-Small Cell Lung Cancer
Ipsen Completes Acquisition of Memo Therapeutics AG, Adding First-in-class Asset to Ipsen’s Rare Disease Pipeline
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
IQIRVO® Demonstrates Statistically Significant Improvement in ALP Normalization in Patients with PBC in Phase IIIb ELSPIRE Study
Dysport® is the First Botulinum Toxin to Achieve Positive Topline Phase III Results in Both Episodic and Chronic Migraine
STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development
Ipsen to Acquire Memo Therapeutics AG - Adding First-in-class BK Polyomavirus Antibody, Expanding Rare Disease Portfolio
Ipsen to Acquire Kartos Therapeutics, Expanding Hemato-oncology Late-stage Pipeline
Ono Pharma Submits a Supplemental Application in Japan to Expand the Use of VELEXBRU® Tablets for the Treatment of Central Nervous System Involvement
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 in Multiple System Atrophy At the 7th World Parkinson Con
Ipsen Announces Late-breaking Data from First Head-to-head Study Comparing Dysport® and Botox® in Adults with Upper Limb Spasticity
Ipsen Unveils Corabotase, A First-in-class Recombinant Neuroinhibitor, RNI™ At the SCALE Symposium
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure
Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)